ASEAN: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in ASEAN

The ASEAN prophylactic medicaments containing insulin market surged to $X in 2023, jumping by X% against the previous year. Overall, consumption continues to indicate a buoyant increase. As a result, consumption attained the peak level and is likely to continue growth in the immediate term.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in ASEAN

In value terms, prophylactic medicaments containing insulin production expanded modestly to $X in 2023 estimated in export price. The total output value increased at an average annual rate of X% over the period from 2012 to 2023; the trend pattern remained relatively stable, with only minor fluctuations in certain years. The pace of growth was the most pronounced in 2013 when the production volume increased by X% against the previous year. Over the period under review, production reached the maximum level at $X in 2021; however, from 2022 to 2023, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in ASEAN

After five years of growth, shipments abroad of medicaments containing insulin but not antibiotics in measured doses decreased by X% to X tons in 2023. In general, exports, however, continue to indicate a significant increase. The pace of growth appeared the most rapid in 2013 with an increase of X%. Over the period under review, the exports hit record highs at X tons in 2022, and then declined in the following year.

In value terms, prophylactic medicaments containing insulin exports dropped to $X in 2023. Over the period under review, exports, however, recorded a significant expansion. The growth pace was the most rapid in 2019 when exports increased by X%. The level of export peaked at $X in 2022, and then contracted in the following year.

Exports by Country

Malaysia dominates exports structure, recording X tons, which was approx. X% of total exports in 2023. It was distantly followed by Singapore (X tons), constituting a X% share of total exports.

Exports from Malaysia increased at an average annual rate of X% from 2012 to 2023. At the same time, Singapore (X%) displayed positive paces of growth. Moreover, Singapore emerged as the fastest-growing exporter exported in ASEAN, with a CAGR of X% from 2012-2023. Malaysia (X p.p.) significantly strengthened its position in terms of the total exports, while Singapore saw its share reduced by X% from 2012 to 2023, respectively.

In value terms, Malaysia ($X) remains the largest prophylactic medicaments containing insulin supplier in ASEAN, comprising X% of total exports. The second position in the ranking was held by Singapore ($X), with a X% share of total exports.

In Malaysia, prophylactic medicaments containing insulin exports expanded at an average annual rate of X% over the period from 2012-2023.

Export Prices by Country

In 2023, the export price in ASEAN amounted to $X per ton, stabilizing at the previous year. In general, the export price showed a abrupt descent. The most prominent rate of growth was recorded in 2017 when the export price increased by X% against the previous year. The level of export peaked at $X per ton in 2012; however, from 2013 to 2023, the export prices remained at a lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2023, amid the top suppliers, the country with the highest price was Singapore ($X per ton), while Malaysia amounted to $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Malaysia (X%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in ASEAN

For the eighth year in a row, ASEAN recorded growth in overseas purchases of medicaments containing insulin but not antibiotics in measured doses, which increased by X% to X tons in 2023. Over the period under review, imports enjoyed prominent growth. The growth pace was the most rapid in 2014 with an increase of X% against the previous year. The volume of import peaked in 2023 and is expected to retain growth in years to come.

In value terms, prophylactic medicaments containing insulin imports expanded rapidly to $X in 2023. Overall, imports saw a resilient expansion. The most prominent rate of growth was recorded in 2014 when imports increased by X%. Over the period under review, imports reached the maximum in 2023 and are likely to see steady growth in the near future.

Imports by Country

In 2023, Malaysia (X tons), distantly followed by Indonesia (X tons), Thailand (X tons), Singapore (X tons), the Philippines (X tons) and Vietnam (X tons) were the key importers of medicaments containing insulin but not antibiotics in measured doses, together creating X% of total imports.

From 2012 to 2023, the biggest increases were recorded for Malaysia (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Indonesia ($X), Vietnam ($X) and Singapore ($X) were the countries with the highest levels of imports in 2023, with a combined X% share of total imports. The Philippines, Malaysia and Thailand lagged somewhat behind, together comprising a further X%.

Malaysia, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in ASEAN stood at $X per ton in 2023, shrinking by X% against the previous year. Overall, the import price saw a noticeable descent. The most prominent rate of growth was recorded in 2018 when the import price increased by X% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2023, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Vietnam ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Malaysia (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform